Veterinary Medicine Information website

AMPIDEXALONE SUSPENSION INJECTABLE POUR BOVINS EQUINS ET PORCINS

Authorised
  • Ampicillin trihydrate
  • Dexamethasone
  • COLISTIN SULFATE
Download as PDF

Product identification

Medicine name:
AMPIDEXALONE SUSPENSION INJECTABLE POUR BOVINS EQUINS ET PORCINS
Active substance:
  • Ampicillin trihydrate
  • Dexamethasone
  • COLISTIN SULFATE
Target species:
  • Cattle
  • Pig
  • Equid
Route of administration:
  • Intramuscular use
  • Subcutaneous use
  • Intraperitoneal use

Product details

Active substance and strength:
  • Ampicillin trihydrate
    100.46
    milligram(s)
    /
    1.00
    millilitre(s)
  • Dexamethasone
    0.25
    milligram(s)
    /
    1.00
    millilitre(s)
  • COLISTIN SULFATE
    0.25
    million international units
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Meat and offal
        21
        day
      • Milk
        5
        day
    • Pig
      • Meat and offal
        21
        day
    • Equid
      • Meat and offal
        21
        day
      • Milk
        5
        day
  • Subcutaneous use
    • Cattle
      • Meat and offal
        21
        day
      • Milk
        5
        day
    • Pig
      • Meat and offal
        21
        day
    • Equid
      • Meat and offal
        21
        day
      • Milk
        5
        day
  • Intraperitoneal use
    • Cattle
      • Meat and offal
        21
        day
      • Milk
        5
        day
    • Pig
      • Meat and offal
        21
        day
    • Equid
      • Meat and offal
        21
        day
      • Milk
        5
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01RV01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • France
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Dopharma France S.A.S.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Dopharma France
Responsible authority:
  • French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
  • FR/V/1053151 8/1989
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 9/07/2024
Download

Package Leaflet and Labelling

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 15/10/2025
Download